HealthEquity FY25 revenue $1.2B (+20% YoY); net income up 74%; guides FY26 above consensus

HEALTHEQUITY, INC.

2025-FY EPS reported $1.09 vs consensus $0.94 ▲ beat (+16.3%)

FY25 revenue $1.20B (+20% YoY); net income $96.7M ($1.09 dilution) vs $55.7M; adjusted EBITDA $471.8M (+28%).
Q4 revenue $311.8M (+19%); net income $26.4M (flat); adj. EBITDA $107.8M (+9%).
HSAs grew 14% to 9.9M; total HSA assets $32.1B (+27%); acquired BenefitWallet portfolio for $425M.
FY26 guidance: revenue $1.28-$1.305B, non-GAAP EPS $3.57-$3.74, adj. EBITDA $525M-$545M.
Repurchased 1.4M shares for $122.2M; $177.8M remaining under buyback.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.